COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 1901: Articles 19001-19010  | Next

Adenovirus and RNA-based COVID-19 vaccines: perceptions and acceptance among healthcare workers
Temsah, M. H., Barry, M., Aljamaan, F., Alhuzaimi, A., Al-Eyadhy, A., Saddik, B., Alsohime, F., Alhaboob, A., Alhasan, K., Alrabiaah, A., Alaraji, A., Halwani, R., Alamro, N., Alshahrani, F., Jamal, A., Alsubaie, S., Memish, Z., Al-Tawfiq, J. A.
10.1101/2020.12.22.20248657 — Posted: 2020-12-24
Reducing contacts to stop SARS-CoV-2 transmission during the second pandemic wave in Brussels, Belgium
Ingelbeen, B., Peckeu, L., Laga, M., Hendrix, I., Neven, I., van der Sande, M. A. B., van Kleef, E.
10.1101/2020.12.23.20248795 — Posted: 2020-12-24
Risk factors for community transmission of SARS-CoV-2. A cross-sectional study in 116,678 people.
Kjetland, E. F., Kalleberg, K. T., Soraas, C. L., Hammarstrom, B., Myklebust, T. A., Jenum, S., Axelsen, E., Lind, A., Bevre-Jensen, R., Jorgensen, S. B., Pettersen, F. O., Solberg, L. B., Hadley, C. L., Istre, M. S., Liestol, K., Dahl, J. A., Ursin, G., Soraas, A.
10.1101/2020.12.23.20248514 — Posted: 2020-12-24
Identifying communities at risk for COVID-19-related burden across 500 U.S. Cities and within New York City
Patel, C. J., Deonarine, A., Lyons, G., Lakhani, C., Manrai, A. K.
10.1101/2020.12.17.20248360 — Posted: 2020-12-24
Coronavirus GenBrowser for monitoring adaptive evolution and transmission of SARS-CoV-2
Yu, D., Yang, X., Tang, B., Pan, Y.-H., Yang, J., Zhu, J., Duan, G., Hao, Z.-Q., Mu, H., Dai, L., Hu, W., Language translation team, , Su, X., Zhang, G.-Q., Zhao, W., Li, H.
10.1101/2020.12.23.20248612 — Posted: 2020-12-24
Hospitalization for self-harm during the early months of the Covid-19 pandemic in France: a nationwide study
Jollant, F., Roussot, A., Corruble, E., CHAUVET-GELINIER, J.-C., Falissard, B., Mikaeloff, Y., Quantin, C.
10.1101/2020.12.18.20248480 — Posted: 2020-12-24
Predicting the Evolution of COVID-19 Mortality Risk: a Recurrent Neural Network Approach
Villegas, M., Gonzalez-Agirre, A., Gutierrez-Fandino, A., Armengol-Estape, J., Carrino, C. P., Perez Fernandez, D., Soares, F., Serrano, P., Pedrera, M., Garcia, N., Valencia, A.
10.1101/2020.12.22.20244061 — Posted: 2020-12-24
Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as per November 20, 2020
Hayer, J., Kasapic, D., Zemmrich, C. S.
10.1101/2020.12.22.20248614 — Posted: 2020-12-24
THE SEARCH FOR AN ASSOCIATION OF HLA ALLELES AND COVID-19 RELATED MORTALITY IN THE RUSSIAN POPULATION
Cheranev, V., Bulusheva, I., Vechorko, V. I., Korostin, D., Rebrikov, D. V.
10.1101/2020.12.22.20248695 — Posted: 2020-12-24
Prevalence of bacterial pathogens and potential role in COVID-19 severity in patients admitted to intensive care units in Brazil
Carvalho, F. M., Lemos, L. N., Ciapina, L. P., Moreira, R. G., Gerber, A., Guimaraes, A. P., Fereguetti, T., Zambelli, V. A. d. A., Avila, R., de Almeida, T. B., Lima, J. S., Barroso, S. P. C., Teixeira, M. M., Souza, R. P., Cardoso, C. C., Aguiar, R. S., Vasconcelos, A. T. R.
10.1101/2020.12.22.20248501 — Posted: 2020-12-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).